TNGX as of Oct 31 · 11:05 ET
TNGXNasdaqPharmaceutical Preparations

Tango Therapeutics, Inc. · Brief

Next report

3 days

Nov 3 · before openest.Q3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 7≥ implied
avg implied
±21.4%
avg realized
±8.7%
Feb 27 '25±18.9%▼−6.44%×0.34
May 12 '25—▲+14.91%—
Aug 5 '25±17.5%▲+4.86%×0.28
Q3 FY25±15.0%0.00%×0.00
Jan 8 '26±30.3%▼−6.23%×0.21
Q1 FY26±42.5%▲+36.28%×0.85
May 13 '26±14.3%▼−2.51%×0.18
Q2 FY26±11.4%▼−4.81%×0.42
quarterimplied−45%0+45%realized×
Q2 FY26±11.4%▼−4.81%×0.42
May '26±14.3%▼−2.51%×0.18
Q1 FY26±42.5%▲+36.28%×0.85
Jan '26±30.3%▼−6.23%×0.21
Q3 FY25±15.0%0.00%×0.00
Aug '25±17.5%▲+4.86%×0.28
2 older reports
May '25—▲+14.91%—
Feb '25±18.9%▼−6.44%×0.34
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull2

4tracked funds holding TNGXN-PORT · Aug 31 '26
247managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

5 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
7 of 7recent reports where the move came in under the options implied rangeEarnings history
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

TNGX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 20impliedImplied move: ±26.5% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.